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Mink enteritis virus (MEV) and Aleutian mink disease parvovirus (ADV) are two mink parvoviruses that replicate permissively in
Crandell feline kidney (CRFK) cells. We have used this cell model to examine if these two mink parvoviruses use the same cellular
receptor. Whereas the cellular receptor for MEV is expected to be the transferrin receptor (TfR), the cellular receptor for ADV has not
been clearly identified. We used short hairpin RNAs (shRNAs) produced from plasmids to trigger RNA interference (RNAi), specifically
and effectively reducing TfR expression in CRFK cells. TfR expression was reduced to levels undetectable by immunofluorescence in the
majority of cells. In viral infection assays, we show that TfR expression was necessary for MEV infection but was not required for ADV
infection. Thus, our results demonstrate that TfR is the cellular receptor for MEV, but not the cellular receptor for ADV. The use of two
different receptors by MEV and ADV to infect the same cell line is yet another difference between these two parvoviruses that may
contribute to their unique pathogenesis in mink.
Published by Elsevier Inc.Keywords: Parvovirus; Aleutian mink disease; Mink enteritis virus; Transferrin receptor; RNAiIntroduction
Mink enteritis virus (MEV) and Aleutian mink disease
parvovirus (ADV) are two autonomous parvoviruses that
cause very different diseases in adult mink. MEV, a viral
variant of feline panleukopenia virus (FPV), causes an acute
disease characterized by high virus replication in mesenteric
lymph nodes and crypt epithelial cells, with an associated
loss of the intestinal mucosa and diarrhea (Reynolds, 1969;
Uttenthal et al., 1990). ADV causes a variable disease
depending on the strain of virus and the mink age, immune
status, and genotype. In seronegative mink kits, ADV
infects alveolar type II pneumocytes and causes an acute
fulminant interstitial pneumonia (Alexandersen, 1986;
Alexandersen and Bloom, 1987; Alexandersen et al.,
1987). However, in adult mink, ADV infection causes a0042-6822/$ - see front matter. Published by Elsevier Inc.
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E-mail address: mbloom@niaid.nih.gov (M.E. Bloom).chronic disease characterized by splenomegaly, hypergam-
maglobulinemia, plasmacytosis, and an acute interstitial
nephritis (Bloom et al., 1988, 1990; Henson et al., 1962;
Mori et al., 1994). Virus replication occurs primarily in
lymph node macrophages where it is restricted, producing
low levels of viral replicative intermediates and virus
progeny.
One factor that may contribute to the tissue tropism and
pathogenesis differences of MEV and ADV is the cellular
receptor. In cell culture, both MEVand ADV infect the same
cell type, Crandell feline kidney (CRFK) cells (Christensen
et al., 1993; Crandell et al., 1973; Storgaard et al., 1993,
1997; Uttenthal et al., 1990). Transferrin receptor 1 (TfR)
has been identified as the cellular receptor utilized by both
FPV and canine parvovirus (CPV) to enter and infect cells
(Parker et al., 2001). CPV is also a viral variant of FPV
(Parrish et al., 1991; Steinel et al., 2001; Truyen et al.,
1995). However, only CPV can infect both feline and canine
cells (Parker et al., 2001). Further characterization has
shown that the host range difference between FPV and CPV2005) 1 – 9
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interaction of VP2 with either the canine or feline TfR
(Govindasamy et al., 2003; Hueffer et al., 2003a, 2003b;
Parker et al., 2001). Although not formally demonstrated,
TfR is expected to be the cellular receptor in CRFK cells for
MEV due to the fact that MEV is a variant of FPV.
The cellular receptor that ADV uses for entry into CRFK
cells has not been clearly identified. Previous studies in our
laboratory have shown that a 67 kDa protein, ADV binding
protein (ABP), binds empty ADV VP2 virions and blocks
attachment to CRFK cells (Fox and Bloom, 1999). Thus, it
is possible that ADV may utilize ABP as its cellular receptor
for entry. However, ABP has not been fully characterized,
and the feline gene for ABP has not been defined. It has
been shown that macrophages are important cells for virus
persistence, and virus-specific antibodies mediate ADV
infection into macrophages via FCgRII (Dworak et al.,
1997). Nevertheless, CRFK cells do not express FCgRII.
Thus, further research into the CRFK cell receptor for ADV
is warranted.
To further characterize the replication of MEV and ADV
in CRFK cells, we sought to determine the role of TfR in
viral entry. Using RNA interference (RNAi) to specifically
abrogate CRFK TfR expression, we observed MEV
infection only in CRFK cells expressing TfR, indicating
that TfR was required for MEV infection. In contrast, ADV
protein expression was detected in CRFK cells with or
without detectable TfR. These results demonstrate that,
while TfR is the cellular receptor for MEV, TfR is not
required for ADV entry. Therefore, MEV and ADV utilize
different cellular receptors to bind and enter CRFK cells.Fig. 1. RNAi knockdown of TfR in CRFK cells. CRFK cells were
transfected with pSEC or pSEC-TfR and after 24 h selected with puromycin
for 48 h before harvesting. (A) Normalized lysates were analyzed by
Western analysis for TfR and h-actin expression (loading control). (B)
Cytospins of cell populations were analyzed by IFA for TfR (red) and PrP
(green) expression. Nuclei of fixed cells were visualized with DAPI (blue).Results
Transferrin receptor knockdown in CRFK cells
The cellular receptor(s) used by MEV and ADV to infect
cells have not been definitively identified. Because MEV is
a viral variant of FPV, it is expected to utilize the same
receptor for entry, namely the TfR (Parker et al., 2001).
Since TfR is expressed on many cell types and both MEV
and ADV infect and replicate in the same host and in CRFK
cells, we tested if TfR was the cellular receptor for both
mink parvoviruses.
We used RNAi to knockdown TfR expression in CRFK
cells and determined if the cells were subsequently permis-
sive to virus infection. To trigger RNAi, we used expression
plasmids that produce short hairpin RNAs (shRNAs) after
transfection into cells. Two plasmids were constructed, pSEC
and pSEC-TfR. Both confer puromycin resistance to trans-
fected cells, but only pSEC-TfR produces shRNAs with a
specific target sequence to TfR mRNAs. The plasmid pSEC
is the background vector of pSEC-TfR and does not produce
any shRNAs. To determine the effect of pSEC-TfR on TfR
expression, plasmids were transfected into CRFK cells, andcells were selected with puromycin. The concentration of
puromycin used resulted in 100% cell death within 48 h post-
transfection for all untransfected cells.
By Western analysis, TfR expression was significantly
reduced in cells containing pSEC-TfR compared to either
untreated or pSEC-transfected CRFK cells (Fig. 1A).
Analyses of normalized amounts of cell lysates showed
that TfR expression was not different between untreated
cells and CRFK cells transfected with pSEC (Fig. 1A).
These results indicate that neither puromycin selection nor
the background vector altered TfR expression.
To further investigate the TfR knockdown, IFA for TfR
was performed. The IFA patterns of TfR expression in both
untreated and pSEC-transfected CRFK cells were consistent
with those previously shown in other cells (van Ooij et al.,
1997), and all cells in these populations expressed TfR (Fig.
1B). Transfection of pSEC-TfR reduced TfR expression to
undetectable levels in 80–95% of cells (Fig. 1B). Never-
theless, a small number of cells in these cultures had levels
of TfR indistinguishable from untreated CRFK cells (Fig.
1B). It is unlikely that these were untransfected cells
because they had survived puromycin selection at a
concentration sufficient to kill all untreated cells. Hence,
transfection of pSEC-TfR effectively abrogates TfR expres-
sion in most transfected cells.
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expression resulted in any non-specific effects on membrane
protein expression, the expression of prion protein (PrP) was
investigated. Western analyses of PrP expression in nor-
malized cellular lysates (Fig. 1A) and IFA (Fig. 1B)
demonstrated that pSEC and pSEC-TfR cell populationsFig. 2. MEV infection of CRFK cells transfected with plasmid constructs. CRFK
and selected with puromycin. Transfected and selected CRFK cells were infected w
104 cells/cytospin) were made from each population of MEV-infected CRFK cel
(green) and TfR (red) gene expression. Cytospins were also counterstained
representative of the populations of MEV-infected plasmid-transfected/selected ce
shRNAs. The plasmids pSEC-TfR, pSEC-Con, and pSEC-Hax produce shRNAs,
known genes (TfR and Hax-1 respectively). (B) The data in panel (A) were quant
for three independent experiments (mean T SEM). (C) The number of MEV-in
express TfR was divided by the total number of cells expressing TfR (mean T SEM
of the denoted value from the average number of MEV-infected cells in the pShad similar levels of PrP compared to untreated cells. Thus,
reducing TfR expression with shRNAs was not the result of
a general inhibition of total membrane protein expression.
Together, these data demonstrated that pSEC-TfR produces
shRNAs that trigger RNAi and result in a specific and
robust reduction of TfR expression.cells were transfected with pSEC, or pSEC-TfR, pSEC-Con, or pSEC-Hax
ith MEV and harvested after 20 h. In each experiment, five cytospins (5 
ls. Cytospins of infected cell populations were analyzed by IFA for MEV
with DAPI to visualize nuclei (blue). (A) The IFA images shown are
lls. The plasmid pSEC provides puromycin resistance but does not produce
however, only pSEC-TfR and pSEC-Hax have specific target sequences to
ified and expressed as the number of MEV-infected cells per 5  104 cells
fected TfR-positive cells. The number of MEV-infected CRFK cells that
). The asterisks denote a significant difference (Student’s t test, P < 0.05)
EC population.
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Transfection of the control plasmid pSEC results in a
population of CRFK cells, all of which express TfR (TfR-
positive) (Fig. 2A). The transfection of pSEC-TfR results in
a population of CRFK cells, most of which have no
detectable TfR (TfR-negative) (Fig. 2A). To determine if
TfR is necessary for MEV to infect CRFK cells, we infected
the pSEC and pSEC-TfR cell populations with MEV and
assayed them for viral gene expression by IFA at 20 h post-
infection. The percentage of TfR-negative cells (83%) in the
pSEC-TfR population remained constant over the course of
the MEV infection, indicating that MEV infection and
replication did not affect the RNAi-mediated reduction of
TfR expression. The only cells that supported MEV
replication were positive for TfR (Fig. 2A). Indeed, there
were no TfR-negative cells infected with MEV in the pSEC-
TfR population, even though more than 80% of the cells
were TfR-negative. In contrast, there were seven-fold more
TfR-positive cells of the control population with detectable
MEVantigen (Fig. 2B). These findings strongly suggest that
TfR was required for MEV to infect CRFK cells.Fig. 3. ADV infection of CRFK cells in control and TfR knockdown cells. CRF
puromycin. Transfected and selected CRFK cells were infected with ADVand harv
were made from each population of ADV-infected CRFK cells and analyzed
counterstained with DAPI (blue). (A) The IFA images shown are representative o
show a representative of the ADV-infected pSEC-TfR cells that do not express TfR
from three independent experiments (mean T SEM).It was possible that the presence of shRNAs may have
non-specific effects on viral gene expression. To better
understand the effects of shRNAs on viral gene expression,
two additional constructs that produce shRNAs and provide
puromycin resistance were used in MEV infection assays.
The plasmid pSEC-Con produces an shRNA with a target
sequence not homologous to any known gene. The plasmid
pSEC-Hax produces an shRNA that has been shown to
knockdown the expression of HS1-associated protein X-1
(HAX-1) (Ortiz et al., 2004). Transfection of CRFK cells with
either of these plasmids did not affect the cellular expression
of TfR (Fig. 2A). Furthermore, MEV gene expression was
detected in both pSEC-Con and pSEC-Hax-transfected
CRFK cells. Together, these results indicate that the shRNA
with the TfR target sequence specifically reduces cellular TfR
expression and that transfection of CRFK cells with shRNA-
producing plasmids does not in itself prevent MEV gene
expression.
We observed nearly a seven-fold reduction in the total
number of pSEC-TfR cells expressing MEV protein com-
pared to the pSEC control cells (Fig. 2B). To determine if
there were differences in the MEV infections of TfR-positiveK cells were transfected with either pSEC or pSEC-TfR and selected with
ested after 72 h. In each experiment, five cytospins (5  104 cells/cytospin)
by IFA for ADV (green) and TfR (red) gene expression. Nuclei were
f the ADV-infected plasmid-transfected/selected cells, except that we only
. (B) The average number of ADV-infected cells per cytospin was calculated
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ized the number of MEV-infected cells to the number of TfR-
positive cells within each population. There was no signifi-
cant difference in the number of normalized infected cells
between the pSEC and pSEC-TfR populations (Fig. 2C, P >
0.05). Thus, MEV infected TfR-positive cells from both
pSEC and pSEC-TfR populations equally. Therefore, the
reduction in the number of MEV-infected pSEC-TfR cells
compared to infected control cells correlates with the
decrease in the number of TfR-positive cells in the pSEC-
TfR population. Interestingly, the number of MEV-infected
TfR-positive cells was reduced in both the pSEC-Con and
pSEC-Hax populations compared to the control cells (Fig.
2C), suggesting that production of an shRNAmaymarginally
inhibit viral gene expression. Together, these results indicate
that TfR is required for MEV to infect CRFK cells.
ADV infection does not require transferrin receptor
expression
To determine if ADV requires TfR to infect CRFK cells,
we infected TfR-positive and TfR-negative CRFK cells with
ADV (Fig. 3A). In contrast to the MEV infection, ADV gene
expression was detected in TfR-negative cells (Fig. 3A) as
well as TfR-positive cells (Fig. 3A). Thus, ADV-infected
CRFK cells in the presence or absence of detectable TfR.
Indeed, there was no significant difference in the total number
of ADV-infected cells between the control and pSEC-TfR
populations (P > 0.05) (Fig. 3B), indicating that ADV-
infected cells from both populations with the same frequency.
This also demonstrates that ADV replication was not blocked
by the depletion of the TfR in CRFK cells. A further inference
from this finding is that the absence of TfR did not inhibit
parvovirus replication per se, arguing against a significant
role for TfR-depletion in affecting cell division in these
studies. Hence, expression of TfR was not a requirement for
ADV entry and replication.Discussion
The permissive replication of MEV and ADV in CRFK
cells has often been compared, and their similarities and
differences have aided in the understanding of the patho-
genesis of two mink parvoviruses. To extend these studies,
our goal was to determine if both viruses use the same cellular
receptor in these cells. Using RNAi technology to ablate TfR
expression in CRFK cells, we determined that TfR expression
was necessary for MEV infection. In contrast, TfR was not
necessary for ADV entry. Thus, two mink parvoviruses that
infect the same cell line must utilize different receptors.
CRFK cell culture is a good model to compare the
permissive replication of both MEV and ADV, as their
replication kinetics in cell culture mimics their viral
replication kinetics in vivo (Christensen et al., 1993; Crandell
et al., 1973; Storgaard et al., 1993, 1997; Uttenthal et al.,1990). There are a number of differences between MEVand
ADV regarding their replication in CRFK cells. For example,
MEV replication in CRFK cells is highest at 24 h post-
infection, whereas ADV replication is slower and does not
reach maximal levels until 72–96 h post-infection (Alex-
andersen et al., 1987; Christensen et al., 1993; Uttenthal et al.,
1990). It has also been shown in CRFK cells that the ADV
viral promoters are weaker than those of MEV and other
prototypical parvoviruses (Christensen et al., 1993; Stor-
gaard et al., 1997). Recent studies have shown that both
MEV and ADV induce apoptosis in infected CRFK cells,
but only ADV requires caspase activation for permissive
replication (Best et al., 2002). We show in this paper that
there is also a requirement for different cellular receptors for
entry into CRFK cells. Thus, we add yet another factor that
further demonstrates that MEV and ADV are two very
different mink parvoviruses. Together, these differences in
cell culture viral replication may help to explain the
differences in tissue tropism and disease following infection
of mink with either MEV or ADV.
In this paper, we reduced TfR expression through shRNA-
mediated RNAi to demonstrate that ADV infected both TfR-
positive and TfR-negative CRFK cells. Because we visually
confirmed the expression of TfR by IFA, we cannot rule out
the possibility that TfRwas expressed in TfR-negative CRFK
cells at amounts lower than our level of detection, but
sufficient for ADV binding and entry. However, the knock-
down of TfR expression was sufficient to abolish MEVentry.
This would imply that, if TfRwas used for entry, then perhaps
ADV interacts with TfR with a higher affinity or association
rate than MEV. Definitive identification of the cellular
receptor used by ADV to infect cells, other than FCgRII,
will assist in understanding the ADV pathogenesis associated
with infection of adult and kit mink. For example, defining
the receptor may enable identification of potential cell and/or
tissue reservoirs of ADV replication in mink that could
contribute to the unique pathogenesis of classical Aleutian
disease (reviewed in Bloom et al., 1994).
RNAi technology is accepted as a valid effective method
to knockdown gene expression. In our results, we also
observed a small but consistent reduction in the number of
MEV-infected cells transfected with the control plasmids
pSEC-Hax and pSEC-Con. It is possible that the knock-
down of HAX-1 expression had a specific effect on MEV
replication as HAX-1 may assist in changing the actin
cytoskeleton and potentially receptor-mediated endocytosis
(Cao et al., 2003; Gallagher et al., 2000; Parker and Parrish,
2000; Wu and Parsons, 1993). However, the same reduction
in the number of MEV-infected cells (Student’s t test, P >
0.05) resulted from triggering RNAi with pSEC-Con. Thus,
our data suggest that inducing RNAi with shRNAs resulted
in non-specific effects on MEV replication. These non-
specific effects may have resulted from an interferon
response to shRNAs as dsRNA and some shRNA vectors
induce interferon (Bridge et al., 2003; Pebernard and Iggo,
2004; Sen, 2001). However, replication of neither MEV nor
Rapid Communication6ADV was reduced in pSEC-TfR cells compared to pSEC
cells. Thus, it is possible that the TfR, Hax, and Con
shRNAs differentially induce interferon responses as the
induction of interferons by short interfering RNAs (siRNAs)
may vary with the particular siRNA (Elbashir et al., 2001;
Kim et al., 2005; Sledz et al., 2003). Thus, only more
detailed analyses of interferon responses to the shRNAs will
provide a better understanding of the effects of shRNAs on
MEV replication.
Off-target effects from control plasmid shRNAs may have
resulted in fewer MEV-infected CRFK cells as siRNAs may
affect gene expression to targets with limited sequence
similarity (Jackson et al., 2003; Persengiev et al., 2004).
Indeed, it has been cautioned that global changes of cellular
gene expression may occur by dsRNA or by triggering RNAi
with microRNAs (Geiss et al., 2001; Lim et al., 2005).
However, the shRNA to TfR did not influence the number of
ADV-infected cells, suggesting that triggering RNAi and
inhibiting TfR expression did not change the cellular
environment sufficiently to affect ADV entry and gene
expression. Although gene silencing may be induced by
DNA viruses as an anti-viral response (reviewed in Voinnet,
2005), it has not been reported that parvoviruses induce gene
silencing. Nevertheless, the decrease in the number of MEV-
infected cells for both control plasmid populations suggests
that RNAi may affect MEV infection. Potentially, this effect
may result from a novel parvovirus–host cell interaction.
Thus, experiments that utilize RNAi with parvoviruses, and
FPV host-range variants in particular, should be carefully
controlled to decipher the specific and non-specific effects of
RNAi knockdown.
Over the course of MEV replication (20 h) observed, the
percentage of TfR-negative cells remained constant (83%). In
contrast, the percentage of TfR-negative cells decreased from
83% to 56% over the 72 h of ADV replication observed (data
not shown). These data suggest that the shRNAwith the TfR
target sequence was less effective in knocking down TfR
expression over an extended period of time, which is
consistent with other published studies that have reduced
gene expression with plasmids expressing shRNAs (Brum-
melkamp et al., 2002; McManus et al., 2002). Because ADV
does not spread in cell culture, the number of cells
expressing ADV protein is reflective of the initial viral
entry events in both control and pSEC-TfR populations. The
important point remains that at 72 h TfR-negative CRFK
cells were infected with ADV. Thus, TfR is not required for
ADV entry, indicating that TfR is not the cellular receptor
for ADV.Materials and methods
Cells and viruses
Crandell feline kidney (CRFK) cells were maintained
in Dulbecco’s modified Eagle medium (DMEM) supple-mented with 10% fetal calf serum (FCS) according to
previously reported methods (Bloom et al., 1990;
Crandell et al., 1973). The MEV-2 Ithaca strain (Uttenthal
et al., 1990) was used for all MEV infections. All ADV
infections were performed with the cell-culture-adapted
ADV-G strain, which was propagated from the molecular
clone as previously described (Bloom et al., 1998).
PCR and plasmid construction
Two TfRs have been discovered in both mice and
humans (TfR1, TfR2), but for the purpose of this paper,
we refer to TfR1 and its homologs in other species as
TfR. The Silencer Express Kit (Ambion, Austin, TX) was
used to construct small interfering RNA Expression
Cassettes (SECs), which express short hairpin RNAs
(shRNAs) to TfR. Possible RNAi TfR targets were
generated using Ambion’s on-line target finder (http://
www.ambion.com/techlib/misc/siRNA_finder.html) and
screened by their identity with TfR cDNA sequences
conserved among several mammalian species. Following
confirmation that sequences were not contained in other
mammalian genes, six expression cassettes containing differ-
ent TfR targets were constructed, and PCR products were
transfected into CRFK cells. TfR knockdown was assayed by
immunofluorescence assay (IFA), and the most efficacious
cassette was cloned into the vector pSEC puro (Ambion) that
provides resistance to puromycin selection (referred to as
pSEC-TfR).
The precursor SEC to each TfR target was generated
according to the manufacturer’s guidelines by two
consecutive PCRs with two template oligonucleotides
using SuperTaq (Ambion) and reagents provided by the
kit. The first PCR for the TfR target contained the sense
oligonucleotide AAACTACACAAATTTCATCTCCACAT-
GACTGCCGGTGTTTCGTCCTTTCCACAAGA, and the
second PCR for the TfR target contained the antisense
oligonucleotide CGGCGAAGCTTTTTCCAAAAAA-
CAGTCATGTGGAGATGAAACTACACAAATTTC. The
TfR target sequence is underlined in the antisense oligonu-
cleotide and corresponds to nucleotides 97 to 117 of the
human TfR1 cDNA. The SEC PCR product for the TfR target
was digested with EcoR1 and HindIII, ligated into pSECTM
puro, and the sequence of pSEC-TfR was confirmed.
A plasmid consisting of pSEC puro with an 85-
nucleotide linker was also constructed (pSEC) and
provides puromycin resistance in transfected cells but
does not express any SEC shRNAs. Two other SECs
were kindly provided by Dr. Dan Ortiz (Tufts University
School of Medicine) and have been previously described
(Ortiz et al., 2004). One of the two SECs produces an
shRNA with a target sequence not homologous to a
known gene, and the second has a target sequence to the
gene HS-1 associated protein X-1 (HAX-1). Both SECs
were cloned into pSEC puro as described above and are
referred to respectively as pSEC-Con and pSEC-Hax.
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Three independent transfections for each plasmid were
performed, and each transfection was infected separately
with MEV or ADV. CRFK cells were transfected with the
constructed plasmids using Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA) according to the manufacturer’s
guidelines for adherent cells with a ratio of 1 Ag plasmid
DNA to 3 Al Lipofectamine 2000 reagent. At 24 h post-
transfection, DMEM (10% FCS) was replaced with fresh
media supplemented with puromycin (5–10 Ag/ml). At 72
h post-transfection, cells were washed three times with
DMEM and once with Dulbecco’s phosphate-buffered
saline (DPBS). Transfected CRFK cells were resuspended
by trypsinization, centrifuged (500  g, 5 min, 4 -C),
resuspended in DMEM, and counted with a hemocytom-
eter. Cells were then seeded into 6-well dishes at 3  105
cells per well and infected 24 h later with MEV (multi-
plicity of infection—MOI = 0.6) or ADV (MOI = 0.4). At
20 h post-infection (hpi), the MEV-infected cells were
harvested by trypsinization, centrifuged (500  g, 5 min, 4
-C), resuspended in DMEM, and counted. ADV-infected
cells were harvested at 72 hpi in the same manner. The
number of infected cells was determined by IFA described
below.
Western blotting, antibodies, and immunofluorescence
assays
Western blotting was performed as previously described
(Fox and Bloom, 1999). Cell lysates were prepared by
resuspending 5  105 untreated or transfected CRFK cells
in standard sample buffer, and their total cellular protein
concentration was determined with a non-interfering
protein assay (Geno Technology, St. Louis, MO). Normal-
ized amounts of total protein were electrophoresed and
blotted onto PVDF membranes. TfR and h-actin were
detected with commercially available monoclonal anti-
bodies (anti-TfR, clone H68.4, 1:200, Zymed, South San
Francisco, CA; anti-h-actin, 1:5000, Novus Biologicals,
Littleton, CO). Unglycosylated PrP was detected with the
monoclonal antibody 3F4 (Lawson et al., 2004) from
normalized amounts of total protein treated with PNGase F
(New England Biolabs, Beverly, MA). All three primary
antibodies were detected with a horseradish peroxidase-
conjugated goat anti-mouse Ig (1:1000) (DAKO Corp.,
Carpinteria, CA).
The TfR antibody used in experiments recognizes the
cytoplasmic, amino-terminus, and was used at a dilution of
1:100 in IFA with the secondary antibody reagent Alexa-
Fluor 568 goat anti-mouse IgG (H + L) (1:1000) (Molecular
Probes, Eugene, OR). Live-cell prion protein (PrP) expres-
sion was detected with a rabbit anti-PrP peptide polyclonal
antisera (R30, 1:1000) (Lawson et al., 2004) and AlexaFluor
488 goat anti-rabbit IgG (H + L) (1:1000) (Molecular
Probes). MEV-infected cells were detected with convales-cent serum from MEV-challenged normal mink (1:100)
(provided by United Laboratories) and AlexaFluor 488
Protein A (1:1000) (Molecular Probes). To detect ADV-
infected cells, a fluorescein-isothiocyanate-conjugated pool
of polyclonal mink anti-ADV (MAD) antisera was used
(1:100) (Bloom et al., 1983).
Indirect IFA was used to detect TfR and PrP expression
and both MEV- and ADV-infected cells. Cytospins of
infected cells were prepared with a Shandon Cytospin 2
by centrifuging 5  104 CRFK cells onto microscope slides.
Five cytospins were made for each transfected plasmid with
each viral infection. Cytospins were either used immediately
in live-cell staining for PrP expression or cells were fixed in
acetone for IFA of TfR expression and detection of MEVor
ADV protein. Cells were incubated with a blocking buffer
(DPBS, 2% normal goat serum, 1% bovine serum albumin,
0.01% NaN3) for 15 min at 37 -C. After blocking, cells were
incubated with the primary antibody reagents for 30 min at
37 -C, washed three times with DPBS, incubated with the
secondary detection reagents for 30 min at 37 -C, washed
three times with DPBS, and rinsed with 95% EtOH.
Cytospins were mounted with ProLong Gold (Molecular
Probes) containing 4V,6V-diamidino-2-phenylindole (DAPI)
to counterstain the nuclei. For live-cell IFA, the blocking
buffer was used as the wash instead of DPBS, and cells were
not rinsed in 95% EtOH. All reagent dilutions were made in
blocking buffer.
Stained cells were examined and counted using a
Nikon Microphot-SA microscope with a mercury lamp,
and images were taken with a Hamamatsu 5985 chilled
CCD camera. The statistical tests used in the data analyses
were either Student’s t test or an analysis of variance
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